Crystal structures of AKR1C3 containing an N-(aryl)amino-benzoate inhibitor and a bifunctional AKR1C3 inhibitor and androgen receptor antagonist. Therapeutic leads for castrate resistant prostate cancer

類似資料

• A 3-(4-Nitronaphthen-1-yl) amino-benzoate analog as a Bifunctional AKR1C3 Inhibitor with AR Antagonist Activity: Head to Head Comparison with Other Advanced AKR1C3 Targeted Therapeutics
  著者:: Wangtrakuldee, Phumvadee, 等
  出版事項: (2019)
• AKR1C3 as a Target in Castrate Resistant Prostate Cancer
  著者:: Adeniji, Adegoke O., 等
  出版事項: (2013)
• Discovery of substituted 3-(phenylamino)benzoic acids as potent and selective inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3)
  著者:: Adeniji, Adegoke O., 等
  出版事項: (2011)
• Selective Inhibitors of Aldo-Keto Reductases AKR1C1 and AKR1C3 Discovered by Virtual Screening of a Fragment Library
  著者:: Brožič, Petra, 等
  出版事項: (2012)
• N-Benzoyl anthranilic acid derivatives as selective inhibitors of aldo–keto reductase AKR1C3
  著者:: Sinreih, Maša, 等
  出版事項: (2012)